UMBRENA

Details for Australian Trade Mark No. 1284439 (hide)

Owner Merck Sharp & Dohme Corp. a New Jersey corporation

Convention US 12 August 2008 77544775

Service Shelston IP

Filing Date 9 February 2009

Classes

Class 5 Pharmaceutical preparations for the treatment of diabetes, cardiovascular diseases and disorders, diseases and disorders of the central nervous system, cancer, obesity, respiratory diseases and disorders, musculoskeletal disorders, osteoporosis, anti-infective preparations, immunological preparations, analgesic preparations

Event Publications

5 March 2009 Application filed

5 March 2009 Application Accepted

23 July 2009 Trade Mark Registered/Protected

28 January 2010 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Merck Sharp & Dohme Corp..

5 July 2012 Subsequent Owners/Holder Registered - Full Assignment

  Schering Corporation is the full asignee of Merck Sharp & Dohme Corp..

26 July 2012 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Merck Sharp & Dohme Corp. a New Jersey corporation.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1284440-PRECIFYL

1284438